The landscape of hepatitis C (HCV) management has undergone a profound shift, yet a stark disconnect remains between clinical efficacy…
Read More
How Sheba Medical Center became OpenAI’s first international hospital partner
The landscape of global healthcare is undergoing a profound transformation as Sheba Medical Center, Israel’s largest and most technologically integrated…
Read More
The oral exposure challenge in PROTACs: What drug developers need to solve early
Proteolysis Targeting Chimera (PROTAC) technology has officially transitioned from a visionary academic concept to a cornerstone of modern clinical pharmacology.…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna advance their…
Read More
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
The American Association of Pharmaceutical Scientists (AAPS) has announced a significant evolution in the agenda for its 2026 PharmSci 360…
Read More
Cancer vaccine borrows COVID immune memory to activate T cells against tumors in mice
The global landscape of immunology has been irrevocably altered by the COVID-19 pandemic, leaving behind a massive, highly specific reservoir…
Read More
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of semi-synthetic alkaloids…
Read More
After decades of trial failures in chemotherapy-linked neuropathy, psilocybin shows promise in preventing it in mice
For millions of cancer survivors, the battle against malignancy does not end with the successful eradication of a tumor. Instead,…
Read More
Pharma commercial vendor selection still runs on word of mouth. A Harvard MBA student aims to change that with Rx Almanac.
For pharmaceutical companies navigating the complex transition from clinical success to commercial launch, the process of selecting service providers—ranging from…
Read More
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The landscape of modern pharmacology is currently undergoing a paradigm shift, one defined by a departure from the rigid structural…
Read More
